14 research outputs found
Π€Π°ΡΠΌΠ°ΠΊΠΎΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΡ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π°Π½Π°Π»ΠΈΠ·Π° ΡΡΠΎΠΈΠΌΠΎΡΡΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ
Background. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations between the subjects of the health care system and medical insurance organizations. The primary morbidity of the population with diseases of the circulatory system increased from 4,784 thousand people in 2018 to 5,136 thousand in 2019. A growth in the number of cases resulted in an increase in the demand for drugs for the treatment of cardiovascular diseases.Objective: to perform a pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents by COI-analysis.Material and methods. The source of information for COI-analysis was the real clinical practice β medical records of sick children and adolescents. A pharmacoeconomic study using COI-analysis was carried out at the inpatient and outpatient stages of care and included the calculation of direct medical costs (the costs of laboratory, instrumental medical services, non-drug and drug antihypertensive therapy). The study included 102 children diagnosed with arterial hypertension. The average stay of patients in the hospital was 10 (10.4Β±0.35) bed-days and treatment on an outpatient basis varied from 3 months to 1 year.Results. The leading place in the structure of costs for antihypertensive therapy is occupied by the beta-blockers pharmacological group (35%). The total cost of arterial hypertension in children and adolescents in inpatient and outpatient settings was 4,459.00 and 29,638.90 rubles, respectively.Conclusion. The COI-analysis of arterial hypertension confirms the need for timely diagnosis and treatment and preventive measures for high blood pressure in children and adolescents to reduce the development of risk factors for such serious cardiovascular complications as stroke and myocardial infarction in adulthood, the treatment of which requires large cash costs.ΠΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ. ΠΠ΅ΡΠΎΠ΄ Π°Π½Π°Π»ΠΈΠ·Π° ΡΡΠΎΠΈΠΌΠΎΡΡΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ (Π°Π½Π³Π». cost of illness, COI) ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ΅Ρ ΠΎΡΠ΅Π½ΠΈΡΡ ΠΈ Π·Π°ΠΏΠ»Π°Π½ΠΈΡΠΎΠ²Π°ΡΡ Π·Π°ΡΡΠ°ΡΡ Π΄Π»Ρ ΡΠ°ΡΡΠ΅ΡΠΎΠ² ΠΌΠ΅ΠΆΠ΄Ρ ΡΡΠ±ΡΠ΅ΠΊΡΠ°ΠΌΠΈ ΡΠΈΡΡΠ΅ΠΌΡ Π·Π΄ΡΠ°Π²ΠΎΠΎΡ
ΡΠ°Π½Π΅Π½ΠΈΡ ΠΈ ΡΡΡΠ°Ρ
ΠΎΠ²ΡΠΌΠΈ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΠΌΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΡΠΌΠΈ. ΠΠ΅ΡΠ²ΠΈΡΠ½Π°Ρ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ Π½Π°ΡΠ΅Π»Π΅Π½ΠΈΡ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ ΡΠΈΡΡΠ΅ΠΌΡ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ Π²ΠΎΠ·ΡΠΎΡΠ»Π° Ρ 4784 ΡΡΡ. ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ Π² 2018 Π³. Π΄ΠΎ 5136 ΡΡΡ. Π² 2019 Π³. Π‘ ΡΠΎΡΡΠΎΠΌ ΡΠΈΡΠ»Π° Π·Π°Π±ΠΎΠ»Π΅Π²ΡΠΈΡ
ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°Π΅ΡΡΡ ΡΠΏΡΠΎΡ Π½Π° Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ.Π¦Π΅Π»Ρ: ΠΏΡΠΎΠ²Π΅ΡΡΠΈ ΡΠ°ΡΠΌΠ°ΠΊΠΎΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΡ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ COI-Π°Π½Π°Π»ΠΈΠ·Π°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΡΠΎΡΠ½ΠΈΠΊΠΎΠΌ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΈ Π΄Π»Ρ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ COI-Π°Π½Π°Π»ΠΈΠ·Π° ΠΏΠΎΡΠ»ΡΠΆΠΈΠ»Π° ΡΠ΅Π°Π»ΡΠ½Π°Ρ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ° β ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΠ΅ ΠΊΠ°ΡΡΡ Π±ΠΎΠ»ΡΠ½ΡΡ
Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ². Π€Π°ΡΠΌΠ°ΠΊΠΎΡΠΊΠΎΠ½ΠΎΠΌΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ COI-Π°Π½Π°Π»ΠΈΠ·Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Π½Π° ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ½ΠΎΠΌ ΠΈ Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΠΎΠΌ ΡΡΠ°ΠΏΠ°Ρ
ΠΎΠΊΠ°Π·Π°Π½ΠΈΡ ΠΏΠΎΠΌΠΎΡΠΈ ΠΈ Π²ΠΊΠ»ΡΡΠΈΠ»ΠΎ ΡΠ°ΡΡΠ΅Ρ ΠΏΡΡΠΌΡΡ
ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ
Π·Π°ΡΡΠ°Ρ, Π° ΠΈΠΌΠ΅Π½Π½ΠΎ Π·Π°ΡΡΠ°Ρ Π½Π° Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΠ΅, ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΡΠ΅ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΠ΅ ΡΡΠ»ΡΠ³ΠΈ, Π½Π΅ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½ΡΠΎΠ·Π½ΡΡ ΠΈ ΠΌΠ΅Π΄ΠΈΠΊΠ°ΠΌΠ΅Π½ΡΠΎΠ·Π½ΡΡ Π°Π½ΡΠΈΠ³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ²Π½ΡΡ ΡΠ΅ΡΠ°ΠΏΠΈΡ. Π ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΈ ΠΎΡΠΎΠ±ΡΠ°Π½Ρ 102 ΡΠ΅Π±Π΅Π½ΠΊΠ° Ρ Π΄ΠΈΠ°Π³Π½ΠΎΠ·ΠΎΠΌ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠΈ. Π‘ΡΠΎΠΊ ΠΏΡΠ΅Π±ΡΠ²Π°Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ΅ Π² ΡΡΠ΅Π΄Π½Π΅ΠΌ ΡΠΎΡΡΠ°Π²ΠΈΠ» 10 (10,4Β±0,35) ΠΊΠΎΠΉΠΊΠΎ-Π΄Π½Π΅ΠΉ, Π° ΡΡΠΎΠΊ Π»Π΅ΡΠ΅Π½ΠΈΡ Π² Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΡΡ
ΡΡΠ»ΠΎΠ²ΠΈΡΡ
β ΠΎΡ 3 ΠΌΠ΅Ρ Π΄ΠΎ 1 Π³ΠΎΠ΄Π°.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΈΠ΄ΠΈΡΡΡΡΡΡ ΠΏΠΎΠ·ΠΈΡΠΈΡ Π² ΡΡΡΡΠΊΡΡΡΠ΅ Π·Π°ΡΡΠ°Ρ Π½Π° Π°Π½ΡΠΈΠ³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΠ²Π½ΡΡ ΡΠ΅ΡΠ°ΠΏΠΈΡ Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ ΡΠ°ΡΠΌΠ°ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ Π³ΡΡΠΏΠΏΠ° Π±Π΅ΡΠ°Π°Π΄ΡΠ΅Π½ΠΎΠ±Π»ΠΎΠΊΠ°ΡΠΎΡΠΎΠ² (35%). ΠΠ±ΡΠ°Ρ ΡΡΠΎΠΈΠΌΠΎΡΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ Β«Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΡΒ» Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Π² ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ½ΡΡ
ΠΈ Π°ΠΌΠ±ΡΠ»Π°ΡΠΎΡΠ½ΡΡ
ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΡΠΎΡΡΠ°Π²ΠΈΠ»Π° 4459,00 ΠΈ 29 638,90 ΡΡΠ±. ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. COI-Π°Π½Π°Π»ΠΈΠ· ΡΡΠΎΠΈΠΌΠΎΡΡΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ Β«Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ Π³ΠΈΠΏΠ΅ΡΡΠ΅Π½Π·ΠΈΡΒ» ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°Π΅Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎΡΡΡ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΈΡ ΡΠ²ΠΎΠ΅Π²ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΈ Π»Π΅ΡΠ΅Π±Π½ΠΎ-ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅ΡΠΎΠΏΡΠΈΡΡΠΈΠΉ ΠΏΡΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΠΎΠΌ Π°ΡΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΌ Π΄Π°Π²Π»Π΅Π½ΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ² Ρ ΡΠ΅Π»ΡΡ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΈΡΠΊΠ° ΡΠ°ΠΊΠΈΡ
ΡΠ΅ΡΡΠ΅Π·Π½ΡΡ
ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ, ΠΊΠ°ΠΊ ΠΈΠ½ΡΡΠ»ΡΡ ΠΈ ΠΈΠ½ΡΠ°ΡΠΊΡ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π°, Π²ΠΎ Π²Π·ΡΠΎΡΠ»ΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡΠ΅, Π»Π΅ΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΡΠΎΡΡΡ
ΡΡΠ΅Π±ΡΠ΅Ρ Π±ΠΎΠ»ΡΡΠΈΡ
Π΄Π΅Π½Π΅ΠΆΠ½ΡΡ
Π·Π°ΡΡΠ°Ρ
EVALUATION OF CHANGES IN TUBERCULOSIS EPIDEMIOLOGICAL RATES AMONG PRISONERS IN THE PENITENTIARY SYSTEM OF RUSSIA AND SMOLENSK REGION
The article presents the results of retrospective analysis of tuberculosis epidemic situation among prisoners in Smolensk Region and its comparison with the same rates in the Russian Federation for 2007-2013. During those years positive changes had been observed in tuberculosis incidence, mortality and prevalence rates. The rates for the region were significantly lower compared to the rates in the penitentiary system for the whole country. Tuberculosis incidence in remand prisons of Smolensk Region was higher compared to the same in penal colonies and overall rate in the penitentiary system of Smolensk Region. Those in the age from 21 to 40 years prevailed among tuberculosis patients in Smolensk Region during the period being analyzed
Π‘ΠΈΠ½Π΄ΡΠΎΠΌ ΠΠ°Π²Π°ΡΠ°ΠΊΠΈ Ρ ΡΠ΅Π±Π΅Π½ΠΊΠ° ΡΠ°Π½Π½Π΅Π³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ°: ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ
Kawasaki syndrome (SC) and multisystem inflammatory syndrome in children (MIS-C) are inflammatory conditions that are difficult for doctors to diagnose and treat. These are two different states, despite the fact that many of their features have common features. Complex pathogenetic mechanisms that cause the development of SC find their clinical expression in the defeat of a large number of functional systems of the body. The aim: demonstrating the difficulty of diagnosing Kawasaki syndrome in a young child of 8 months. Results. The emphasis is placed on the clinical predominance of intoxication-febrile, respiratory, intestinal, exanthemic syndromes, as well as on the absence of specific symptoms from the cardiovascular system in the early stages of the disease, which made early diagnosis difficult. Conclusion. The clinical case we have presented demonstrates the atypical development of Kawasaki syndrome with a prolonged absence of changes from the cardiovascular systemΠ‘ΠΈΠ½Π΄ΡΠΎΠΌ ΠΠ°Π²Π°ΡΠ°ΠΊΠΈ (Π‘Π) ΠΈ ΠΌΡΠ»ΡΡΠΈΡΠΈΡΡΠ΅ΠΌΠ½ΡΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ Ρ Π΄Π΅ΡΠ΅ΠΉ (MIS-C) ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΡΡ ΡΠΎΠ±ΠΎΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ, ΠΊΠΎΡΠΎΡΡΠ΅ ΡΡΡΠ΄Π½Ρ Π΄Π»Ρ Π²ΡΠ°ΡΠ΅ΠΉ Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠΈ. ΠΡΠΎ Π΄Π²Π° ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΡΠΎΡΡΠΎΡΠ½ΠΈΡ, Π½Π΅ΡΠΌΠΎΡΡΡ Π½Π° ΡΠΎ, ΡΡΠΎ ΠΌΠ½ΠΎΠ³ΠΈΠ΅ ΠΈΡ
ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΠΈΠΌΠ΅ΡΡ ΠΎΠ±ΡΠΈΠ΅ ΡΠ΅ΡΡΡ. Π‘Π»ΠΎΠΆΠ½ΡΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΡ, ΠΎΠ±ΡΡΠ»Π°Π²Π»ΠΈΠ²Π°ΡΡΠΈΠ΅ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π‘Π, Π½Π°Ρ
ΠΎΠ΄ΡΡ ΡΠ²ΠΎΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π²ΡΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ Π² ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΠΈ Π±ΠΎΠ»ΡΡΠΎΠ³ΠΎ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΈ ΡΠΈΡΡΠ΅ΠΌ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ°. Π¦Π΅Π»Ρ: Π΄Π΅ΠΌΠΎΠ½ΡΡΡΠ°ΡΠΈΡ ΡΡΡΠ΄Π½ΠΎΡΡΠΈ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΠ°Π²Π°ΡΠ°ΠΊΠΈ Ρ ΡΠ΅Π±Π΅Π½ΠΊΠ° 8 ΠΌΠ΅ΡΡΡΠ΅Π². Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π‘Π΄Π΅Π»Π°Π½ Π°ΠΊΡΠ΅Π½Ρ Π½Π° ΠΌΡΠ»ΡΡΠΈΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΡΡΠΈ ΠΏΠΎΡΠ°ΠΆΠ΅Π½ΠΈΡ ΠΎΡΠ³Π°Π½ΠΎΠ², Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌ ΠΎΡΡΡΡΡΡΠ²ΠΈΠΈ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΠΌΠΏΡΠΎΠΌΠ°ΡΠΈΠΊΠΈ ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ, ΡΡΠΎ ΠΏΡΠΈΠ²Π΅Π»ΠΎ ΠΊ ΠΏΠΎΠ·Π΄Π½Π΅ΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΠ°Π²Π°ΡΠ°ΠΊΠΈ Ρ ΡΠ΅Π±Π΅Π½ΠΊΠ°. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈΠ²Π΅Π΄Π΅Π½Π½ΡΠΉ Π½Π°ΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ Π΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΡΠ΅Ρ Π½Π΅ΡΠΈΠΏΠΈΡΠ½ΠΎΠ΅ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° ΠΠ°Π²Π°ΡΠ°ΠΊΠΈ Ρ Π΄Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ΠΌ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ
ΠΠ»ΠΈΡΠ½ΠΈΠ΅ ΠΌΠΎΡΠ±ΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Π½Π° ΠΈΡΡ ΠΎΠ΄ COVID-19 Ρ ΡΠ΅Π±Π΅Π½ΠΊΠ°
Numerous works of domestic and foreign colleagues have proved that obesity is an independent risk factor for severe COVID-19 among patients of all age groups. Of particular interest is the study of the effect of overweight on the course of a new coronavirus infection in children and adolescents.Objective. Demonstration of a clinical case of fatal outcome of COVID-19 in a patient with morbid obesity; analysis and generalization of current data on the effect of obesity on the course of a new coronavirus infection in pediatric patients.The article presents a general understanding of the pathogenetic relationship between the two pathologies, as well as a case of a fatal outcome of a new coronavirus infection in a 9-year-old 4-month-old girl with morbid obesity (BMI β 39 kg/m2, SDS BMI +4.98Ο). Emphasis is placed on the lack of parallelism between the results of the procalcitonin test and the development of the septic process.Conclusion. Studies of domestic and foreign colleagues, as well as the clinical case we have cited, confirm that morbid obesity is a risk factor for the adverse course of COVID-19 in children.Π ΠΌΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΡ
ΡΠ°Π±ΠΎΡΠ°Ρ
ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΈ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΡΡ
ΠΊΠΎΠ»Π»Π΅Π³ Π΄ΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ Π½Π΅Π·Π°Π²ΠΈΡΠΈΠΌΡΠΌ ΡΠ°ΠΊΡΠΎΡΠΎΠΌ ΡΠΈΡΠΊΠ° ΡΡΠΆΠ΅Π»ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ COVID-19 ΡΡΠ΅Π΄ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π²ΡΠ΅Ρ
Π²ΠΎΠ·ΡΠ°ΡΡΠ½ΡΡ
Π³ΡΡΠΏΠΏ. ΠΡΠΎΠ±ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ Π²Π»ΠΈΡΠ½ΠΈΡ ΠΈΠ·Π±ΡΡΠΎΡΠ½ΠΎΠΉ ΠΌΠ°ΡΡΡ ΡΠ΅Π»Π° Π½Π° ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π½ΠΎΠ²ΠΎΠΉ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ ΠΈ ΠΏΠΎΠ΄ΡΠΎΡΡΠΊΠΎΠ².Π¦Π΅Π»Ρ: Π΄Π΅ΠΌΠΎΠ½ΡΡΡΠ°ΡΠΈΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ»ΡΡΠ°Ρ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡ
ΠΎΠ΄Π° COVID-19 Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ Ρ ΠΌΠΎΡΠ±ΠΈΠ΄Π½ΡΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ; Π°Π½Π°Π»ΠΈΠ· ΠΈ ΠΎΠ±ΠΎΠ±ΡΠ΅Π½ΠΈΠ΅ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΡ
Π½Π° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ Π΄Π°Π½Π½ΡΡ
ΠΎ Π²Π»ΠΈΡΠ½ΠΈΠΈ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΡ Π½Π° ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π½ΠΎΠ²ΠΎΠΉ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Ρ ΠΏΠ΅Π΄ΠΈΠ°ΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ².Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΎ ΠΎΠ±ΡΠ΅Π΅ ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ²ΡΠ·ΠΈ Π΄Π²ΡΡ
ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΉ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½ ΡΠ»ΡΡΠ°ΠΉ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΡΡ
ΠΎΠ΄Π° Π½ΠΎΠ²ΠΎΠΉ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Ρ Π΄Π΅Π²ΠΎΡΠΊΠΈ 9 Π»Π΅Ρ 4 ΠΌΠ΅ΡΡΡΠ΅Π² Ρ ΠΌΠΎΡΠ±ΠΈΠ΄Π½ΡΠΌ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ΠΌ (ΠΈΠ½Π΄Π΅ΠΊΡ ΠΌΠ°ΡΡΡ ΡΠ΅Π»Π° (ΠΠΠ’) β 39 ΠΊΠ³/ΠΌ2, ΠΊΠΎΡΡΡΠΈΡΠΈΠ΅Π½Ρ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠΊΠ»ΠΎΠ½Π΅Π½ΠΈΡ β Standard Deviation Score (SDS) ΠΠΠ’ β +4,98Ο). Π‘Π΄Π΅Π»Π°Π½ Π°ΠΊΡΠ΅Π½Ρ Π½Π° ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ ΠΏΠ°ΡΠ°Π»Π»Π΅Π»ΠΈΠ·ΠΌΠ° ΠΌΠ΅ΠΆΠ΄Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌΠΈ ΠΏΡΠΎΠΊΠ°Π»ΡΡΠΈΡΠΎΠ½ΠΈΠ½ΠΎΠ²ΠΎΠ³ΠΎ ΡΠ΅ΡΡΠ° ΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ΠΌ ΡΠ΅ΠΏΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΈ Π·Π°ΡΡΠ±Π΅ΠΆΠ½ΡΡ
ΠΊΠΎΠ»Π»Π΅Π³, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½Π½ΡΠΉ Π½Π°ΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°ΡΡ, ΡΡΠΎ ΠΌΠΎΡΠ±ΠΈΠ΄Π½ΠΎΠ΅ ΠΎΠΆΠΈΡΠ΅Π½ΠΈΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ°ΠΊΡΠΎΡΠΎΠΌ ΡΠΈΡΠΊΠ° Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ COVID-19 Ρ Π΄Π΅ΡΠ΅ΠΉ
Π’ΡΠΈΠ³Π³Π΅ΡΠ½Π°Ρ ΡΠΎΠ»Ρ COVID-19 Π² ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΡΠ°Ρ Π°ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΠ°Π±Π΅ΡΠ° 1-Π³ΠΎ ΡΠΈΠΏΠ° ΠΈ ΠΊΠ΅ΡΠΎΠ°ΡΠΈΠ΄ΠΎΠ·Π° Ρ ΡΠ΅Π±Π΅Π½ΠΊΠ°: ΡΠ»ΡΡΠ°ΠΉ ΠΈΠ· ΠΏΡΠ°ΠΊΡΠΈΠΊΠΈ
It has been proven that the SARS-CoV-2 virus is able to initiate the development of a number of metabolic disorders, leading to diabetes mellitus (DM). Given the high frequency of cases of newly diagnosed type 1 diabetes in children, as well as possible adverse prospective consequences, the study of such clinical cases seems to us to be an extremely relevant practice for doctors of all specialties. The aim of the study was to to demonstrate of a clinical case of newly diagnosed type 1 diabetes in a child with COVID-19.The article presents a general understanding of the pathogenetically bidirectional relationship between a new coronavirus infection and diabetes mellitus, presents a clinical case of type 1 diabetes diagnosed for the first time in a child 3 years 8 months with COVID-19, and describes the further stage of treatment in the specialized endocrinology department.Conclusion. The clinical case presented by us, as well as data obtained as a result of research by domestic and foreign colleagues, confirm the existence of a pathogenetically determined relationship between COVID-19 and type 1 diabetes mellitus in children. To better understand the mechanisms underlying the devel- opment of metabolic suffering, it is necessary to create a single Global registry of patients with diabetes mellitus, first identified in connection with COVID-19.ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π²ΠΈΡΡΡ SARS-CoV-2 ΡΠΏΠΎΡΠΎΠ±Π΅Π½ ΠΈΠ½ΠΈΡΠΈΠΈΡΠΎΠ²Π°ΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΡΡΠ΄Π° ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ
Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ, ΠΏΡΠΈΠ²ΠΎΠ΄Ρ ΠΊ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ ΡΠ°Ρ
Π°ΡΠ½ΠΎΠ³ΠΎ Π΄ΠΈΠ°Π±Π΅ΡΠ° (Π‘Π). Π£ΡΠΈΡΡΠ²Π°Ρ Π²ΡΡΠΎΠΊΡΡ ΡΠ°ΡΡΠΎΡΡ ΡΠ»ΡΡΠ°Π΅Π² Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π²ΡΡΠ²Π»Π΅Π½Π½ΠΎΠ³ΠΎ Π‘Π 1-Π³ΠΎ ΡΠΈΠΏΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ, Π° ΡΠ°ΠΊΠΆΠ΅ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΡΠ΅ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠ΅ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΠ²ΠΈΡ, ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠ΄ΠΎΠ±Π½ΡΡ
ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ»ΡΡΠ°Π΅Π² ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅ΡΡΡ Π½Π°ΠΌ ΠΊΡΠ°ΠΉΠ½Π΅ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠΎΠΉ Π΄Π»Ρ Π²ΡΠ°ΡΠ΅ΠΉ Π²ΡΠ΅Ρ
ΡΠΏΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ. Π¦Π΅Π»Ρ: ΠΎΠΏΠΈΡΠ°Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ»ΡΡΠ°Ρ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π²ΡΡΠ²Π»Π΅Π½Π½ΠΎΠ³ΠΎ Π‘Π 1-Π³ΠΎ ΡΠΈΠΏΠ° Ρ ΡΠ΅Π±Π΅Π½ΠΊΠ° Ρ COVID-19.Π ΡΡΠ°ΡΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΎ ΠΎΠ±ΡΠ΅Π΅ ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ Π΄Π²ΡΠ½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠΉ ΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ Π½ΠΎΠ²ΠΎΠΉ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ ΠΈ ΡΠ°Ρ
Π°ΡΠ½ΡΠΌ Π΄ΠΈΠ°Π±Π΅ΡΠΎΠΌ, ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π²ΡΡΠ²Π»Π΅Π½Π½ΠΎΠ³ΠΎ Π‘Π 1-Π³ΠΎ ΡΠΈΠΏΠ° Ρ ΡΠ΅Π±Π΅Π½ΠΊΠ° 3 Π»Π΅Ρ 8 ΠΌΠ΅ΡΡΡΠ΅Π², Π±ΠΎΠ»Π΅ΡΡΠ΅Π³ΠΎ COVID-19, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎΠΏΠΈΡΠ°Π½ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠΈΠΉ ΡΡΠ°ΠΏ Π»Π΅ΡΠ΅Π½ΠΈΡ Π² ΠΏΡΠΎΡΠΈΠ»ΡΠ½ΠΎΠΌ ΡΠ½Π΄ΠΎΠΊΡΠΈΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠΈ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΠΈΠ²Π΅Π΄Π΅Π½Π½ΡΠΉ Π½Π°ΠΌΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠ»ΡΡΠ°ΠΉ ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π°Π΅Ρ ΡΡΡΠ΅ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½ΠΎΠΉ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ COVID-19 ΠΈ ΡΠ°Ρ
Π°ΡΠ½ΡΠΌ Π΄ΠΈΠ°Π±Π΅ΡΠΎΠΌ 1-Π³ΠΎ ΡΠΈΠΏΠ° Ρ Π΄Π΅ΡΠ΅ΠΉ. ΠΠ»Ρ Π»ΡΡΡΠ΅Π³ΠΎ ΠΏΠΎΠ½ΠΈΠΌΠ°Π½ΠΈΡ ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ², Π»Π΅ΠΆΠ°ΡΠΈΡ
Π² ΠΎΡΠ½ΠΎΠ²Π΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΡΡΠ°Π΄Π°Π½ΠΈΠΉ, Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΡΠΎΠ·Π΄Π°Π½ΠΈΠ΅ Π΅Π΄ΠΈΠ½ΠΎΠ³ΠΎ ΠΠ»ΠΎΠ±Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π΅ΡΡΡΠ° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠ°Ρ
Π°ΡΠ½ΡΠΌ Π΄ΠΈΠ°Π±Π΅ΡΠΎΠΌ, Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π²ΡΡΠ²Π»Π΅Π½Π½ΡΠΌ Π² ΡΠ²ΡΠ·ΠΈ Ρ COVID-19
ΠΠΎΠ²Π°Ρ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½Π°Ρ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ Π² ΠΏΠ΅Π΄ΠΈΠ°ΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΏΡΠ°ΠΊΡΠΈΠΊΠ΅: ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ COVID-19 Π² Π³ΠΎΡΠΎΠ΄Π΅ Π‘ΠΌΠΎΠ»Π΅Π½ΡΠΊΠ΅
The aim of the study was to study the clinical and epidemiological features of the new COVID-19 coronavirus infection in children hospitalized in the infectious department. Material and methods. 249 case histories of patients from 0 to 18 years of age who are on inpatient treatment at Β«Clinical Hospital N1Β» in Smolensk for the period from April 2020 to July 2022 were studied by the continuous sampling method. Verification of a new coronavirus infection was carried out by examining smears from the nasopharynx and oropharynx for the presence of SARS-CoV-2 by real-time PCR. Results. The prevalence of patients from 1 to 3 (19.3%, 49.1%) and from 6β15 (15.8%, 50.5%) years was revealed both in 2020 and in 2021 and the first half of 2022. No significant differences in gender were found. The largest number of cases in 2020 was registered in April (16%) and November (14%), in 2021 β in December (18%) and November (16%). The prevailing severity in both 2020 and 2021, 2022 was the average severity (63% , 72%, 93%, respectively). The main syndromes of COVID-19 have been identified: intoxication syndrome, respiratory catarrhal syndrome, bronchopulmonary, intestinal. Bilateral pneumonia was most often detected (47% in 2020 , 44% in 2021, 62% in 2022), right-sided pneumonia (33% in 2020, 30% in 2021, 31% in 2022 ), and left-sided pneumonia (20%, 26% and 7%, respectively). The main comorbid pathologies are noted, and cases of somatic diseases first registered against the background of COVID-19 are described.Β Π¦Π΅Π»Ρ: Π°Π½Π°Π»ΠΈΠ· ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ Π½ΠΎΠ²ΠΎΠΉ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ COVID-19 Ρ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π² ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠ΅ ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ Π΄Π΅ΡΠ΅ΠΉ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ΅ΡΠΎΠ΄ΠΎΠΌ ΡΠΏΠ»ΠΎΡΠ½ΠΎΠΉ Π²ΡΠ±ΠΎΡΠΊΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΎ 249 ΠΈΡΡΠΎΡΠΈΠΉ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 0 Π΄ΠΎ 18 Π»Π΅Ρ, Π½Π°Ρ
ΠΎΠ΄ΠΈΠ²ΡΠΈΡ
ΡΡ Π½Π° ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ½ΠΎΠΌ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π² ΠΠΠΠ£Π Β«ΠΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠ°Ρ Π±ΠΎΠ»ΡΠ½ΠΈΡΠ° β1Β» Π³. Π‘ΠΌΠΎΠ»Π΅Π½ΡΠΊΠ° Π·Π° ΠΏΠ΅ΡΠΈΠΎΠ΄ Ρ Π°ΠΏΡΠ΅Π»Ρ 2020 ΠΏΠΎ ΠΈΡΠ»Ρ 2022 Π³Π³. ΠΠ΅ΡΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π½ΠΎΠ²ΠΎΠΉ ΠΊΠΎΡΠΎΠ½Π°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ ΠΏΡΡΠ΅ΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΌΠ°Π·ΠΊΠΎΠ² ΠΈΠ· Π½ΠΎΡΠΎΠ³Π»ΠΎΡΠΊΠΈ ΠΈ ΡΠΎΡΠΎΠ³Π»ΠΎΡΠΊΠΈ Π½Π° Π½Π°Π»ΠΈΡΠΈΠ΅ SARS-CoV-2 ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ¦Π Π² ΡΠ΅ΠΆΠΈΠΌΠ΅ ΡΠ΅Π°Π»ΡΠ½ΠΎΠ³ΠΎ Π²ΡΠ΅ΠΌΠ΅Π½ΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΡΠ²Π»Π΅Π½ΠΎ ΠΏΡΠ΅ΠΎΠ±Π»Π°Π΄Π°Π½ΠΈΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 1 Π΄ΠΎ 3-Ρ
(19,3%, 49,1%) ΠΈ ΠΎΡ 6β15 Π»Π΅Ρ (15,8%, 50,5%) ΠΊΠ°ΠΊ Π² 2020, ΡΠ°ΠΊ ΠΈ Π² 2021 ΠΈ ΠΏΠ΅ΡΠ²ΠΎΠΉ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Π΅ 2022 Π³. ΠΠΎΡΡΠΎΠ²Π΅ΡΠ½ΡΡ
ΡΠ°Π·Π»ΠΈΡΠΈΠΉ ΠΏΠΎ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠΌΡ ΠΏΡΠΈΠ·Π½Π°ΠΊΡ Π½Π΅ ΠΎΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΎ. ΠΠ°ΠΈΠ±ΠΎΠ»ΡΡΠ΅Π΅ ΡΠΈΡΠ»ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²ΡΠΈΡ
Π² 2020 Π³.Π·Π°ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π½ΠΎ Π² Π°ΠΏΡΠ΅Π»Π΅ (16%) ΠΈ Π½ΠΎΡΠ±ΡΠ΅ (14%), Π² 2021 Π³. β Π² Π΄Π΅ΠΊΠ°Π±ΡΠ΅ (18%) ΠΈ Π½ΠΎΡΠ±ΡΠ΅ (16%). ΠΡΠ΅ΠΎΠ±Π»Π°Π΄Π°ΡΡΠ΅ΠΉ ΠΈ Π² 2020, ΠΈ Π² 2021, ΠΈ Π² 2022 Π³Π³. ΠΎΠΊΠ°Π·Π°Π»Π°ΡΡ ΡΡΠ΅Π΄Π½ΡΡ ΡΡΠ΅ΠΏΠ΅Π½Ρ ΡΡΠΆΠ΅ΡΡΠΈ (63%, 72%, 93% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ). ΠΡΡΠ²Π»Π΅Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΡΠΈΠ½Π΄ΡΠΎΠΌΡ COVID-19: ΡΠΈΠ½Π΄ΡΠΎΠΌ ΠΈΠ½ΡΠΎΠΊΡΠΈΠΊΠ°ΡΠΈΠΈ, ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎ-ΠΊΠ°ΡΠ°ΡΠ°Π»ΡΠ½ΡΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ, Π±ΡΠΎΠ½Ρ
ΠΎΠ»Π΅Π³ΠΎΡΠ½ΡΠΉ, ΠΊΠΈΡΠ΅ΡΠ½ΡΠΉ. ΠΠ°ΠΈΠ±ΠΎΠ»Π΅Π΅ ΡΠ°ΡΡΠΎ Π²ΡΡΠ²Π»ΡΠ»Π°ΡΡ Π΄Π²ΡΡΡΠΎΡΠΎΠ½Π½ΡΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΡ (47% β Π² 2020, 44% β Π² 2021, 62% β Π² 2022), Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΎ ΡΠ΅ΠΆΠ΅ β ΠΏΡΠ°Π²ΠΎΡΡΠΎΡΠΎΠ½Π½ΡΡ (33% β Π² 2020, 30% β Π² 2021, 31% β Π² 2022 Π³Π³.), ΠΈ Π»Π΅Π²ΠΎΡΡΠΎΡΠΎΠ½Π½ΡΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΡ (20%, 26% ΠΈ 7% ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ). ΠΡΠΌΠ΅ΡΠ΅Π½Ρ ΠΎΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΊΠΎΠΌΠΎΡΠ±ΠΈΠ΄Π½ΡΠ΅ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΎΠΏΠΈΡΠ°Π½Ρ ΡΠ»ΡΡΠ°ΠΈ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ Π·Π°ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π½Π° ΡΠΎΠ½Π΅ COVID-19 ΡΠΎΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ
ΠΠ¦ΠΠΠΠ ΠΠΠΠΠΠΠΠ ΠΠΠΠΠΠΠΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ₯ ΠΠΠΠΠΠΠ’ΠΠΠΠ ΠΠ Π’Π£ΠΠΠ ΠΠ£ΠΠΠΠ£ Π‘Π ΠΠΠ Π‘ΠΠΠ¦ΠΠΠΠ’ΠΠΠΠΠΠ’Π Π£ΠΠΠΠΠΠΠ-ΠΠ‘ΠΠΠΠΠΠ’ΠΠΠ¬ΠΠΠ Π‘ΠΠ‘Π’ΠΠΠ« Π ΠΠ‘Π‘ΠΠΠ‘ΠΠΠ Π€ΠΠΠΠ ΠΠ¦ΠΠ Π Π‘ΠΠΠΠΠΠ‘ΠΠΠ ΠΠΠΠΠ‘Π’Π
The article presents the results of retrospective analysis of tuberculosis epidemic situation among prisoners in Smolensk Region and its comparison with the same rates in the Russian Federation for 2007-2013. During those years positive changes had been observed in tuberculosis incidence, mortality and prevalence rates. The rates for the region were significantly lower compared to the rates in the penitentiary system for the whole country. Tuberculosis incidence in remand prisons of Smolensk Region was higher compared to the same in penal colonies and overall rate in the penitentiary system of Smolensk Region. Those in the age from 21 to 40 years prevailed among tuberculosis patients in Smolensk Region during the period being analyzed.ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ ΡΠ΅ΡΡΠΎΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΡΠΏΠΈΠ΄Π΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΡΡΠ°ΡΠΈΠΈ ΠΏΠΎ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Ρ ΡΡΠ΅Π΄ΠΈ ΡΠΏΠ΅ΡΠΊΠΎΠ½ΡΠΈΠ½Π³Π΅Π½ΡΠ° Π‘ΠΌΠΎΠ»Π΅Π½ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ Π² ΡΡΠ°Π²Π½Π΅Π½ΠΈΠΈ Ρ ΡΠ°ΠΊΠΎΠ²ΡΠΌΠΈ Π΄Π°Π½Π½ΡΠΌΠΈ ΠΏΠΎ Π ΠΎΡΡΠΈΠΉΡΠΊΠΎΠΉ Π€Π΅Π΄Π΅ΡΠ°ΡΠΈΠΈ Π·Π° 2007-2013 Π³Π³. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° Π½Π°Π±Π»ΡΠ΄Π°Π²ΡΠ°ΡΡΡ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ° Π² ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΠΈ, ΡΠΌΠ΅ΡΡΠ½ΠΎΡΡΠΈ ΠΈ ΡΠ°ΡΠΏΡΠΎΡΡΡΠ°Π½Π΅Π½Π½ΠΎΡΡΠΈ. ΠΠ°Π½Π½ΡΠ΅ ΠΏΠΎ ΡΠ΅Π³ΠΈΠΎΠ½Ρ Π±ΡΠ»ΠΈ Π·Π½Π°ΡΠΈΠΌΠΎ Π½ΠΈΠΆΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΏΠΎ ΠΏΠ΅Π½ΠΈΡΠ΅Π½ΡΠΈΠ°ΡΠ½ΠΎΠΌΡ ΡΠ΅ΠΊΡΠΎΡΡ ΡΡΡΠ°Π½Ρ. ΠΠ°Π±ΠΎΠ»Π΅Π²Π°Π΅ΠΌΠΎΡΡΡ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·ΠΎΠΌ Π² ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΈΠ·ΠΎΠ»ΡΡΠΎΡΠ°Ρ
Π‘ΠΌΠΎΠ»Π΅Π½ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ Π²ΡΡΠ΅ ΡΠ°ΠΊΠΎΠ²ΠΎΠΉ Π² ΠΈΡΠΏΡΠ°Π²ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΊΠΎΠ»ΠΎΠ½ΠΈΡΡ
ΠΈ ΠΎΠ±ΡΠ΅Π³ΠΎ Π·Π½Π°ΡΠ΅Π½ΠΈΡ ΠΈΠ½Π΄ΠΈΠΊΠ°ΡΠΎΡΠ° Π² ΠΏΠ΅Π½ΠΈΡΠ΅Π½ΡΠΈΠ°ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΠ΅ ΡΠ΅Π³ΠΈΠΎΠ½Π°. Π‘ΡΠ΅Π΄ΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²ΡΠΈΡ
Π² Π‘ΠΌΠΎΠ»Π΅Π½ΡΠΊΠΎΠΉ ΠΎΠ±Π»Π°ΡΡΠΈ Π² Π°Π½Π°Π»ΠΈΠ·ΠΈΡΡΠ΅ΠΌΠΎΠΌ ΠΏΠ΅ΡΠΈΠΎΠ΄Π΅ ΠΏΡΠ΅ΠΎΠ±Π»Π°Π΄Π°Π»ΠΈ Π»ΠΈΡΠ° Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 21-40 Π»Π΅Ρ
LOW DOSAGE ACETYLSALICYLIC ACID: A VARIETY OF FORMULATIONS
The most prevalent formulation of the low-dosage (ld) acetylsalicylic acid (ASA) for prevention purposes is the gut soluble pill β 80,6% of the ldASA registered in pharmacy market. Formulations of ldASA mostly presented as ASA monodrugs (84,4%), containing only ASA as active substance, predominantly as 100 mg dosage. Amount of ASA of 81 mg has become widespread only in North America, that is related to nonmetric measurement system. Combinational ldASA with non-soluble antacide (magnesium hydroxide) are not broadly used throughout the world β 1,6% of all pharmacy market registered labels, and mostly in use in the regions of former USSR
Pharmacological activity of polyphenolic connections in the conditions of alcoholic intoxication
In experiment it is shown cardionegative action of spirit ethyl. Damaging effects can be fixed with the help bioimpedansometry which is one of ways of an estimation of a condition of cellular membranes. It is noticed, that indicators bioimpedansometry correlate with presence of morphological changes in fabrics under the influence of ethyl spirit and the medicinal substances lowering a medicinal intoxication